These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 25200487)

  • 81. [Clinical trials for medicinal products. New European and national legal rules].
    Kreutz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061
    [TBL] [Abstract][Full Text] [Related]  

  • 82. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2013 May; 78(102):31944-5. PubMed ID: 23724425
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The 10th edition of the USSR Government Pharmacopoeia as a standard for medicinal plant raw material].
    Linchenko NA
    Farmatsiia; 1969; 18(6):5-8. PubMed ID: 5383454
    [No Abstract]   [Full Text] [Related]  

  • 85. International reference preparations for standardization of biological medicinal products.
    Minor P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1145-51. PubMed ID: 25204274
    [TBL] [Abstract][Full Text] [Related]  

  • 86. European Union directives and their effect on the registration and authorisation of anthroposophic and homeopathic medicines.
    Laso LR; Alfonso-Galán MT
    Med Law; 2009 Mar; 28(2):269-82. PubMed ID: 19705642
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Registration of new medicinal products in Europe].
    Singer E
    Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interpretation of size-exclusion chromatography for the determination of molecular-size distribution of human immunoglobulins.
    Christians S; Schluender S; van Treel ND; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2016; 2016():115-28. PubMed ID: 27593533
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Collaborative studies for the establishment of reference substances for the microbiological assay of antibiotics.
    Charton E; Daas AG; Sandrin J; Miller JH
    Pharmeuropa Bio; 2004 Jan; 2003(2):1-8. PubMed ID: 14960259
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR; Luttkopf D; Seitz R; Vieths S
    Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
    [TBL] [Abstract][Full Text] [Related]  

  • 92. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Could EU herbal monographs contribute to Malta's treatment armamentarium?
    Micallef B; Attard E; Serracino-Inglott A; Borg JJ
    Phytomedicine; 2015 Mar; 22(3):400-5. PubMed ID: 25837278
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.
    van Galen E
    J Ethnopharmacol; 2014 Dec; 158 Pt B():498-502. PubMed ID: 25043781
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

  • 97. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Apr; 75(64):17148-9. PubMed ID: 20383923
    [TBL] [Abstract][Full Text] [Related]  

  • 98. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Apr; 75(69):18509-10. PubMed ID: 20387318
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 100. "Eurocode International Blood Labeling System" enables unique identification of all biological products from human origin in accordance with the European Directive 2004/23/EC.
    Knels R; Mönig HJ; Wittmann G; von Versen R; Pruss A
    Cell Tissue Bank; 2010 Nov; 11(4):345-52. PubMed ID: 20563859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.